Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.

@article{Bostom1996HyperhomocysteinemiaHA,
  title={Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study.},
  author={Andrew G. Bostom and Douglas G. Shemin and Kate L. Lapane and Patrice Sutherland and Marie R. Nadeau and Peter W. F. Wilson and David Yoburn and Linda L Bausserman and Geoff Tofler and Paul F Jacques and Jacob S Selhub and Irwin H. Rosenberg},
  journal={Atherosclerosis},
  year={1996},
  volume={125 1},
  pages={91-101}
}
Maintenance dialysis patients experience an exceedingly high incidence of arteriosclerotic cardiovascular disease (CVD) events that are poorly predicted by traditional CVD risk factor indices. We evaluated the prevalence of three non-traditional CVD risk factors, i.e. hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) Lp(a)) excess, and combined hyperhomocysteinemia, hyperfibrinogenemia, and Lp(a) excess, in maintenance dialysis patients. Fasting total plasma homocysteine (Hcy… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 23 extracted citations

Similar Papers

Loading similar papers…